Found 52 matching trials
Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population N/A The goal of the study is to provide a detailed description of treatments fo...
Show More Location
Multiple Locations
Learn More & Join Trial
BAY88-8223, Does Response Study in HRPC Patients PHASE2 The purpose of this study is to evaluate the efficacy and safety of the inv...
Show More Location
Multiple Locations
Learn More & Join Trial
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer N/A This study investigates how well radium-223 works in treating patients with...
Show More Location
Johns Hopkins University
Learn More & Join Trial
A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones PHASE1 In this study researcher want to gain more information on how the study dru...
Show More Location
Uniklinikum Salzburg - Landeskrankenhaus
Learn More & Join Trial
Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer PHASE2 This phase 2 trial studies radium Ra 223 dichloride, hormone therapy and st...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Navigant Study- Treatment Patterns in mCRPC (Metastatic Castrate Resistant Prostate Cancer ) N/A Categorize the clinical parameters and patient determinants that drive phys...
Show More Learn More & Join Trial
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones PHASE2 This phase II trial studies how well radium-223 dichloride and paclitaxel w...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Treatment Satisfaction With Ra-223 in Japan N/A This study aims to answer the research question: Are Japanese bone metastat...
Show More Learn More & Join Trial
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer) PHASE4 Researchers in this study want to compare how well drug radium-223 dichlori...
Show More Status
Active Not Recruiting
Location
Specialist Services Medical Group
Learn More & Join Trial
A Study to Learn More About How Radium-223 is Being Used With Other Treatments in European Patients Who Have Not Received Radium-223 Before N/A In this study data from people with metastatic castration-resistant prostat...
Show More Learn More & Join Trial